StockNews.com Begins Coverage on Tenax Therapeutics (NASDAQ:TENX)
StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Separately, Roth Mkm reiterated a buy rating and set a $6.00 target price on shares of Tenax Therapeutics in a research report on Monday, […]
More Stories
COPT Defense Properties (NYSE:CDP) Trading Up 1.8% on Analyst Upgrade
Shares of COPT Defense Properties (NYSE:CDP – Get Free Report) traded up 1.8% during mid-day trading on Wednesday after BTIG...
Adams Diversified Equity Fund (NYSE:ADX) Trading Down 0.6% – Here’s Why
Shares of Adams Diversified Equity Fund, Inc. (NYSE:ADX – Get Free Report) traded down 0.6% on Wednesday . The company...
Home Depot (NYSE:HD) Shares Up 0.4% – Time to Buy?
The Home Depot, Inc. (NYSE:HD – Get Free Report) shares traded up 0.4% during mid-day trading on Wednesday . The...
Harris Campaign Managers Blame Election Loss on ‘Ferocious Headwinds,’ Limited Time
By Matt McGregor Campaign managers behind Kamala Harris’s presidential bid blamed her loss to President-elect Donald Trump on their limited...
Best Buy Posts Weak Earnings and Sales as Customers Wait for Deals
By Panos Mourdoukoutas Big-box retailer Best Buy posted weak earnings and sales in the fourth quarter of 2024 as competition...
Ways to Prevent and Improve Fatty Liver Disease Naturally
By Naiwen Hu Fatty liver disease is one of the most common health conditions today. It develops when fat makes...